gsk-429286a (6f6f8113-b23a-4266-aae4-21910aaf47f0) (Collection)

Project:

Drugmonizome

Dcc Asset:

IDG C2M2 2024-01-09 datapackage validated.zip

Dcc:

IDG

Compound:

N-(6-fluoro-1H-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-pyridine-5-carboxamide

Collection:

6f6f8113-b23a-4266-aae4-21910aaf47f0.json

Persistent Id:6f6f8113-b23a-4266-aae4-21910aaf47f0.json

Description:Metadatata for gsk-429286a

Creation Time:2021-09-08T00:00:00

Linked to

	Label	Description
	N-(6-fluoro-1H-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-pyridine-5-carboxamide Compound (Entity type)	nan
	6f6f8113-b23a-4266-aae4-21910aaf47f0.json File (Entity type)	A file from IDG as part of the Drugmonizome project

N-(6-fluoro-1H-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-pyridine-5-carboxamide

nan

6f6f8113-b23a-4266-aae4-21910aaf47f0.json

A file from IDG as part of the Drugmonizome project

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.